Gavin Yamey

Yamey earned his Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) from University College London in 1994 and his Master's in public health from the London School of Hygiene & Tropical Medicine in 2010.[1] Upon receiving his M.B.B.S, Yamey worked in a variety of London teaching hospitals and completed his public health training at the London School of Hygiene and Tropical Medicine. He finished his medical training at Oxford University and University College London, qualifying as a physician in 1994 and becoming a member of the Royal College of Physicians in 1997.[2]

Yamey moved to San Francisco in 2001 to become the deputy editor of the Western Journal of Medicine while also remaining an assistant editor for The BMJ. By 2004, he was appointed as a founding senior editor of PLOS Medicine and was the principal investigator on a grant from the Bill & Melinda Gates Foundation to support the launch of PLoS Neglected Tropical Diseases.[2] A few years later, Yamey received a Kaiser Family Foundation Mini-Fellowship in Global Health Reporting to write editorials in East Africa for PLoS Medicine.[3] As a professor at the UCSF School of Medicine, Yamey served on two international health commissions, the Lancet Commission on Investing in Health and the Lancet Commission on Global Surgery, and led the writing of "Global Health 2035" which was published on December 3, 2013.[2]

In 2015, Yamey joined the Duke University Global Health Institute faculty as a professor of the practice of global health and public policy. and an associate director in the Institute responsible for leading a global health policy initiative.[4] While serving in this role, he was a co-author on a report titled "Global Surgery 2030: A Roadmap for High Income Country Actors," which was meant to be used as a roadmap to expand access to surgical care around the world.[5] Yamey followed this up by presenting the "Investing in Health: The Economic Case" at the World Innovation Summit for Health to promote investing in cost-effective health interventions.[6] In recognition of his efforts, Yamey became the director of the newly established the Center for Policy Impact in Global Health at Duke.[7]

As the director of the Center for Policy Impact in Global Health, Yamey and his research team address questions in global health, particularly related to its financing, governance, architecture and delivery. The Center team used the Portfolio-to-Impact (P2I) model to analyze candidate medicines, vaccines, diagnostics and other technologies at various stages of development in an effort to calculate the costs of developing these products. They estimated that it would cost about $16.3 billion to produce 538 highly effective candidate products.[8] Earlier in the year, Yamey had been nominated and awarded Dukes' Outstanding Undergraduate Professor Award.[9]

Prior to the COVID-19 pandemic, Yamey published an op-ed titled "The Odds of a Devastating Pandemic Just Went Up" which was critical of Trump administration's decision to scale back investments for pandemic prevention and response.[10] Once the pandemic hit, Yamey collaborated with researchers to co-author Ensuring global access to COVID-19 vaccines, which listed suggestion on how to best deploy the vaccine to the population.[11] As a result, he also worked alongside David McAdams and the World Health Organization to map out strategies for deploying an effective COVID-19 vaccine worldwide.[12]

Yamey practices Judaism.[13]